Lixisenatide Patent Expiration
Lixisenatide is used for improving glycemic control in patients with type 2 diabetes mellitus. It was first introduced by Sanofi-Aventis Us Llc
Lixisenatide Patents
Given below is the list of patents protecting Lixisenatide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Adlyxin | US10201663 | Assembly for a drug delivery device | Mar 10, 2034 | Sanofi-aventis Us |
| Adlyxin | US9408893 | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients | Aug 27, 2032 | Sanofi-aventis Us |
| Adlyxin | US9821032 | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin | May 09, 2032 | Sanofi-aventis Us |
| Adlyxin | US9072836 | Drive mechanism for a drug delivery device and drug delivery device | Mar 15, 2032 | Sanofi-aventis Us |
| Adlyxin | US9440029 | Drive mechanism for a drug delivery device and drug delivery device | Jan 30, 2032 | Sanofi-aventis Us |
| Adlyxin | US9511193 | Assembly and indicator for a drug delivery device | Jan 19, 2032 | Sanofi-aventis Us |
| Adlyxin | US9084853 | Drive mechanism for a drug delivery device and drug delivery device | Oct 05, 2031 | Sanofi-aventis Us |
| Adlyxin | US8882721 | Drive assembly suitable for use in a drug delivery device and drug delivery device | Jun 28, 2031 | Sanofi-aventis Us |
| Adlyxin | US8475414 | Medication delivery device and method for operating a medication delivery device | Dec 28, 2030 | Sanofi-aventis Us |
| Adlyxin | US9308329 | Medication delivery device and method for operating a medication delivery device | Dec 28, 2030 | Sanofi-aventis Us |
| Adlyxin | US10028910 | Pharmaceutical composition comprising a GLP-1-agonist and methionine | Nov 11, 2030 | Sanofi-aventis Us |
| Adlyxin | US9707176 | Pharmaceutical composition comprising a GLP-1 agonist and methionine | Nov 11, 2030 | Sanofi-aventis Us |
| Adlyxin | US9981013 | Use of AVE0010 for the treatment of diabetes mellitus type 2 | Aug 30, 2030 | Sanofi-aventis Us |
| Adlyxin | US8915888 | Dosing and drive mechanism for drug delivery device | Jun 08, 2030 | Sanofi-aventis Us |
| Adlyxin | US9855388 | Dosing and drive mechanism for drug delivery device | Apr 24, 2029 | Sanofi-aventis Us |
| Adlyxin | USRE45313 | Exendin variant peptides |
Jul 12, 2020
(Expired) | Sanofi-aventis Us |
Lixisenatide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List